Neurociencias - GIC 21/019
Universidad de Cantabria
Santander, EspañaPublicaciones en colaboración con investigadoras/es de Universidad de Cantabria (9)
2024
-
Dysregulated FOXO1 activity drives skeletal muscle intrinsic dysfunction in amyotrophic lateral sclerosis
Acta Neuropathologica, Vol. 148, Núm. 1
2023
-
Cumulative Genetic Score and C9orf72 Repeat Status Independently Contribute to Amyotrophic Lateral Sclerosis Risk in 2 Case-Control Studies
Neurology: Genetics, Vol. 9, Núm. 4
2021
-
Amyotrophic lateral sclerosis (ALS), cancer, autoimmunity and metabolic disorders: An unsolved tantalizing challenge
British Journal of Pharmacology, Vol. 178, Núm. 6, pp. 1269-1278
-
Clinical and preclinical evidence of somatosensory involvement in amyotrophic lateral sclerosis
British Journal of Pharmacology, Vol. 178, Núm. 6, pp. 1257-1268
2020
-
ALS-derived fibroblasts exhibit reduced proliferation rate, cytoplasmic TDP-43 aggregation and a higher susceptibility to DNA damage
Journal of Neurology, Vol. 267, Núm. 5, pp. 1291-1299
-
Dermic-derived fibroblasts for the study of amyotrophic lateral sclerosis
Neural Regeneration Research, Vol. 15, Núm. 11, pp. 2043-2044
2019
-
Amyotrophic lateral sclerosis: A complex syndrome that needs an integrated research approach
Neural Regeneration Research, Vol. 14, Núm. 2, pp. 193-196
2018
-
The increasing importance of environmental conditions in amyotrophic lateral sclerosis
International Journal of Biometeorology, Vol. 62, Núm. 8, pp. 1361-1374
2017
-
Distribution and genotype-phenotype correlation of GDAP1 mutations in Spain
Scientific Reports, Vol. 7, Núm. 1